Vella F S, Simone B, Carella A, Schiraldi O, Antonaci S
Dipartimento di Clinica Medica, Immunologia e Malattie Infettive, Università, Bari.
Recenti Prog Med. 2000 Jul-Aug;91(7-8):365-7.
Common variable immunodeficiency (CVID) is a primary immunodeficiency disease characterized by severe and recurrent infections which affect both lung and gastrointestinal systems. On the contrary, central nervous system involvement, related to virus infections, is an important, rare and usually fatal complication occurring in a later phase of the disease. Furthermore, CVID may predispose to a variety of autoimmune diseases. Here, we report the case of a 20 years old girl who developed acute disseminated encephalomyelitis as the first clinical feature in CVID. The infective agent was not determined and there was no history of recent vaccinations. CVID was diagnosed on the basis of the significant reduction of serum immunoglobulin concentration, in the absence of either diseases responsible for secondary immunodeficiency or functional and/or quantitative abnormalities of lymphocyte subsets, phagocytes and complement fractions. The treatment with high doses of native intravenous immunoglobulins (IVIG) combined with corticosteroids in the early phase led to a complete recovery with restitutio ad integrum. This case outlines the possible relationship between autoimmune diseases and infections in CVID, as suggested by the finding of either viral encephalitis in CVID patients and the well-known autoimmune pathogenesis of acute disseminated encephalomyelitis. In such a condition, the combination of IVIG and corticosteroids may offer considerable advantages in terms of therapeutical efficacy.
普通可变免疫缺陷(CVID)是一种原发性免疫缺陷疾病,其特征为严重且反复的感染,累及肺部和胃肠道系统。相反,与病毒感染相关的中枢神经系统受累是该疾病后期出现的一种重要、罕见且通常致命的并发症。此外,CVID可能易患多种自身免疫性疾病。在此,我们报告一例20岁女孩的病例,她以急性播散性脑脊髓炎作为CVID的首发临床特征。未确定感染病原体,且近期无疫苗接种史。CVID的诊断基于血清免疫球蛋白浓度显著降低,且不存在导致继发性免疫缺陷的疾病,也不存在淋巴细胞亚群、吞噬细胞和补体成分的功能和/或定量异常。早期使用大剂量天然静脉注射免疫球蛋白(IVIG)联合皮质类固醇进行治疗,使患者完全康复,恢复如初。该病例概述了CVID中自身免疫性疾病与感染之间可能的关系,这一关系由CVID患者中出现病毒性脑炎以及急性播散性脑脊髓炎众所周知的自身免疫发病机制所提示。在这种情况下,IVIG和皮质类固醇的联合使用在治疗效果方面可能具有相当大的优势。